Prognostic value of codon 918 (ATG?ACG)RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
- 20 January 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested materialBritish Journal of Cancer, 1996
- Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytomaBritish Journal of Cancer, 1996
- RET receptor tyrosine kinase gene mutations: molecular biological, physiological and clinical aspectsEuropean Journal of Clinical Investigation, 1996
- Mechanism of Activation of the ret Proto-oncogene by Multiple Endocrine Neoplasia 2A MutationsMolecular and Cellular Biology, 1995
- Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC: sHuman Molecular Genetics, 1994
- Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumoursHuman Molecular Genetics, 1994
- One gene—four syndromesNature, 1994
- A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomaNature, 1994
- Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung diseaseHuman Molecular Genetics, 1993
- PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomasCell, 1990